May 31, 2011
Galderma Laboratories Inc. and Supernus Pharmaceuticals Inc. hit generic drug maker Impax Laboratories Inc. with a patent infringement suit Thursday in Delaware over Impax's bid for regulatory approval to market its own version of the rosacea treatment Oracea.